Insider Transactions
| Date | Filer | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|
| Mar 31, 2020 |
Director
Trans History: 143
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 257 | $92.23 | 19,464 |
| Mar 31, 2020 |
Director
Trans History: 61
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 501 | $92.23 | 7,143 |
| Mar 31, 2020 |
Director
Trans History: 74
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 325 | $92.23 | 7,498 |
| Mar 31, 2020 |
Director
Trans History: 147
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 352 | $92.23 | 25,622 |
| Mar 31, 2020 |
Director
Trans History: 8
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 271 | $92.23 | 736 |
| Mar 11, 2020 |
Director
Trans History: 143
|
Form 4 | Open market or private purchase of non-derivative or derivative security | 2,000 | $121.00 | 6,000 |
| Mar 11, 2020 |
Director
Trans History: 143
|
Form 4 | Open market or private purchase of non-derivative or derivative security | 2,000 | $123.00 | 8,000 |
| Mar 09, 2020 |
Director
Trans History: 143
|
Form 4 | Open market or private purchase of non-derivative or derivative security | 2,000 | $122.00 | 2,000 |
| Mar 09, 2020 |
Director
Trans History: 143
|
Form 4 | Open market or private purchase of non-derivative or derivative security | 2,000 | $124.00 | 4,000 |
| Mar 04, 2020 |
SVP, CLO and Secretary
Trans History: 146
|
Form 4 | Open market or private sale of non-derivative or derivative security | 3,000 | $135.24 | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.